24.07.2018 11:30:00
|
Infosys Named a 'Leader' in IDC MarketScape Worldwide Life Science R&D ITO Services Vendor Assessment 2018
BENGALURU, India, July 24, 2018 /PRNewswire/ --
Infosys has been recognized as a Leader in the IDC MarketScape report, 'Worldwide Life Science R&D ITO Services 2018 Vendor Assessment'. IDC rated Infosys highly for the value it delivers to its customers relative to cost, quality of its ITO work, and willingness to contribute strategically to operational efforts.
(Logo: https://mma.prnewswire.com/media/633365/Infosys_Logo.jpg )
The IDC study is the second document of a three-part series (BPO, ITO, and strategic consulting) that examines IT outsourcing in the life science R&D space. With a specific focus on life science R&D ITO, this report compares 11 major IT service providers based on operational, business, and market-centric criteria that should be important to life science companies when considering the selection of an external service provider to take over non-core IT activities.
Infosys has been serving the life science industry for more than 13 years and has over 5,000 workforce dedicated to its life science practice. Within the life science and R&D ITO space, Infosys is strong in delivering data and applications development and management, technology infrastructure and cloud implementation and support, and testing services to its clients. The extensive network of delivery centers also enables Infosys to offer its customers flexibility for project engagements. According to IDC, while growing its efforts with eminent pharmaceutical companies, Infosys has created a significant industry footprint that appeals to companies of all sizes.
For more information contact PR_global@infosys.com
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Infosys Ltd. (spons. ADRs)mehr Nachrichten
11.02.25 |
NASDAQ Composite Index-Papier Infosys-Aktie: So viel Verlust hätte eine Infosys-Investition von vor 3 Jahren eingebracht (finanzen.at) | |
04.02.25 |
NASDAQ Composite Index-Papier Infosys-Aktie: So viel hätten Anleger mit einem Investment in Infosys von vor einem Jahr verdient (finanzen.at) | |
28.01.25 |
NASDAQ Composite Index-Wert Infosys-Aktie: So viel Gewinn hätte eine Infosys-Investition von vor 10 Jahren eingebracht (finanzen.at) | |
21.01.25 |
NASDAQ Composite Index-Papier Infosys-Aktie: So viel Gewinn hätte ein Investment in Infosys von vor 5 Jahren eingefahren (finanzen.at) | |
16.01.25 |
NASDAQ-Handel NASDAQ Composite schwächelt zum Handelsende (finanzen.at) | |
16.01.25 |
Schwacher Handel: NASDAQ Composite am Nachmittag im Minus (finanzen.at) | |
16.01.25 |
Anleger in New York halten sich zurück: NASDAQ Composite leichter (finanzen.at) | |
16.01.25 |
Angespannte Stimmung in New York: NASDAQ Composite fällt zum Start zurück (finanzen.at) |
Analysen zu Infosys Ltd. (spons. ADRs)mehr Analysen
Aktien in diesem Artikel
Infosys Ltd | 1 856,30 | 0,71% |
|
Infosys Ltd. (spons. ADRs) | 20,50 | -0,49% |
|